Covamlo (5+50) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Stancare (Ranbaxy Laboratories Ltd). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Losartan Potassium, Amlodipine Besilate. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 67.5 (arround $0.945 US Dollar)
Generic (Salt) Combination :
(Losartan Potassium+ Amlodipine Besilate)
Pharma Company :
Stancare (Ranbaxy Laboratories Ltd)
Brand Label :
Covamlo (5+50)
Preparation Type :
Tablet
Single Dose :
1 Tablet
Composition (Fixed-Dose Combination) :
Amlodipine Besilate-5 mg
Losartan Potassium-50 mg
Pack Size/Qty/Vol :
10 Tablet
Price Unit :
Rs 6.75 INR (arround $0.0945 US Dollar)
Price Pack :
Rs 67.5 INR (arround $0.945 US Dollar)
Drug details for Covamlo (5+50)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Covamlo (5+50) are :
Amlodipine Besilate-5 mg
Losartan Potassium-50 mg
Losartan Potassium Indication (Prescribed for or used as): Mild to moderate hypertension. Diabetic nephropathy in type 2 diabetes mellitus.
For more details on Losartan Potassium, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Losartan Potassium..
Amlodipine Besilate Indication (Prescribed for or used as):
For more details on Amlodipine Besilate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Amlodipine Besilate..
Covamlo (5+50) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 2 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Covamlo (5+50), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Amlodipine Besilate-5 mg Losartan Potassium-50 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.